nad tirzepatide Chemical structures of Semaglutide (A), and (B), recently NAD+ with Tirzepatide: Safer, Energising

Extracellular fluid volume expansion uncovers a natriuretic action of GLP1: A functional GLP1renal Axis in man

Now the FDA is pushing the ad industry toward it too

FIGURE 3 Cholinesterase inhibitors (ChEIs) and NMDA receptor antagonists, such as donepezil, lisinopril, galantamine, and memantine, are the most common FDA-approved treatments but only address symptoms and can cause side effects like bradycardia and extrapyramidal symptoms, without directly targeting A deposition

[DOI] [PMC free article] [PubMed] [Google Scholar] 111.Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., et al